✦ LIBER ✦

P114 ADALIMUMAB SAFETY IN CROHN'S DISEASE: A SUB-ANALYSIS OF IMMUNOSUPPRESSANT AND STEROID USE IN THE CHARM TRIAL

✍ Scribed by J.F. Colombel; W.J. Sandborn; W. Reinisch; S.B. Hanauer; P. Rutgeerts; J. Li; P.F. Pollack

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P079 BENEFITS OF DOSAGE ADJUSTMENT WITH

✍ W.J. Sandborn; J.F. Colombel; P. Rutgeerts; P.F. Pollack; J. Chao; P. Mulani 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 71 KB

P104 A NATIONWIDE AUDIT OF ADALIMUMAB US

✍ R.K. Russell; M.L. Wilson; N. Shah; G. Mahdi; W. Hyer; C. Spray; I. Davies; R. H 📂 Article 📅 2009 🏛 Oxford University Press ⚖ 51 KB

M1143 Benefits of Dosage Adjustment with

✍ Sandborn, William J.; Colombel, Jean-Frédéric; Rutgeerts, Paul; Pollack, Paul F. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Adalimumab for Maintenance of Clinical R

✍ Jean–Frédéric Colombel; William J. Sandborn; Paul Rutgeerts; Robert Enns; Stephe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 712 KB

P136 - Efficacy and safety of adalimumab

✍ F. Civitelli; F. Viola; S. Oliva; F. Nuti; E. Romeo; G. Di Nardo; V. Pannone; O. 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 43 KB

P003 - The ACCESS trial: impact of adali

✍ R. Panaccione; E.V. Loftus Jr.; D. Binion; K. McHugh; N. Chen; B. Guérette; P. M 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 115 KB